End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
22.55 USD | +3.73% | +1.76% | +116.83% |
May. 16 | HC Wainwright Initiates Dianthus Therapeutics With Buy Rating, $40 Price Target | MT |
May. 10 | Wedbush Adjusts Dianthus Therapeutics' Price Target to $38 From $33, Keeps Outperform Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+116.83% | 662M | |
+18.72% | 125B | |
+14.53% | 109B | |
-2.88% | 24.74B | |
+4.69% | 22.67B | |
-9.42% | 18.14B | |
-41.04% | 16.67B | |
-11.83% | 16.64B | |
+1.46% | 13.45B | |
+24.22% | 11.32B |
- Stock Market
- Equities
- DNTH Stock
- News Dianthus Therapeutics, Inc.
- HC Wainwright Initiates Dianthus Therapeutics With Buy Rating, $40 Price Target